🧠 Latest Migraine Updates: Migraine Autoinjector Approval, MS Drug Advances, Tau Biomarkers & More!
In this week’s Neuroscience Updates, we spotlight pivotal breakthroughs shaping the future of neurology and neurodegenerative disease treatment.
✨ Key updates include:
✅ FDA approves Brekiya – the first ready-to-use DHE autoinjector for migraine and cluster headache, available H2 2025
💊 Quantum BioPharma preps IND for Lucid-21-302, a first-in-class, non-immunomodulatory treatment for Multiple Sclerosis
🌍 Gensco acquires global rights to RizaFilm & RizaPort, waterless ODF migraine treatments set for U.S. launch in Q4 2025
🧬 Cure Rare Disease receives FDA Orphan Drug Designation for SCA3 RNA-based therapy backed by $5.7M in funding
⏳ Biohaven’s troriluzole FDA review delayed to Q4 2025, maintaining Priority Review for potential first SCA treatment
🤝 AbbVie & ADARx ink $335M upfront RNA therapy deal targeting neuroscience and oncology indications
🧪 Alamar Biosciences launches blood-based tau panel for Alzheimer’s early detection with high specificity
🔬 Dyno Therapeutics unveils AI-powered AAV vectors for brain, muscle, and eye—validated in primates
🧪 AviadoBio kicks off Phase 1/2 Aspire-FTD trial in the UK using AVB-101 gene therapy for GRN-linked FTD
🧒 BrainChild Bio gets RMAT for BCB-276 CAR T therapy, targeting DIPG via direct CSF infusion
⚡ Capsida’s CAP-002 cleared by FDA for STXBP1-DEE clinical trial with brain-wide expression and reduced liver targeting
🧠 Latus Bio unveils AAV-Ep+ vector enabling potent, low-dose brain-wide protein delivery—validated in mice and primates
Whether you’re in clinical development, biotech R&D, or healthcare strategy, this roundup keeps you informed on the latest innovations transforming brain health.
📢 Stay Ahead in Neuroscience Research!
✅ Like, share, and subscribe for weekly updates on neuroscience, neurodegeneration, and clinical trials
#NeuroscienceNews #MigraineTreatment #MultipleSclerosis #GeneTherapy #Alzheimers #FDAApproval #ClinicalTrials #NeurodegenerativeDisease #HealthcareInnovation #LucidQuest #BiotechNews #BrainHealth